Leading developer of unique behavioral based technology and services, Ubic Inc. (ADR) (NASDAQ:UBIC), has announced the appointment of Paul Starret as the company’s Chief Corporate officer. Paul will still continue to perform his duties as the company’s Chief Global Risk Officer for North America as well as perform other duties under his new role. Ubic Inc (ADR) (NASDAQ:UBIC) shares after opening at $6.65 moved to $7.20 on last trade day and at the end of the day closed at $7.06. Company price to sales ratio in past twelve months was calculated as 21.89. Ubic Inc (ADR) (NASDAQ:UBIC) showed a positive weekly performance of 2.47%.
Investors in Baltic Trading Ltd (NYSE:BALT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BALT options chain for the new May 17th contracts and identified the following call contract of particular interest. Baltic Trading Ltd (NYSE:BALT) shares advanced 6.39% in last trading session and ended the day on $6.49. BALT return on equity ratio is recorded as -5.30% and its return on assets is -3.80%. Baltic Trading Ltd (NYSE:BALT) yearly performance is 84.37%.
Empresas ICA SA (ADR) (NYSE:ICA), which had led the construction of the Mexico City subway- line which is now partly closed for repairs, dropped the most in 8 months as it said that it was owed over $200 million for that project. Corporativo GBM SAB’s analyst Javier Gayol in Mexico City, said that the city is 1 of the most-important clients that Empresas ICA SA (ADR) (NYSE:ICA) could have. Any kind of bad relationship could definitely hamper its ability to get any new projects in that area. Empresas ICA SA (ADR) (NYSE:ICA) shares moved up 5.86% in last trading session and was closed at $6.68, while trading in range of $6.34-$6.73. Empresas ICA SA (ADR) (NYSE:ICA) year to date performance is -20.95%.
Exact Sciences Corp. (NASDAQ:EXAS) announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public. The net proceeds to Exact from this offering are expected to be approximately $119.7 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Exact.The offering is expected to close on or about April 9, 2014, subject to the satisfaction of customary closing conditions. Exact has granted the underwriters a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock. EXACT Sciences Corporation (NASDAQ:EXAS) weekly performance is 6.22%. On last trading day company shares ended up $13.66. EXACT Sciences Corporation (NASDAQ:EXAS) distance from 50-day simple moving average is 1.61%. Analysts mean target price for the company is $18.50.
Leave a Reply